Consultation Services

NI Research offers consultation regarding strategic planning and licensing and alliance opportunities within the universe of the micro to midsize CNS companies that comprise our field of primary interest. We do not offer competitive intelligence services. Recent consultation projects have included:

1. Strategic planning for a small CNS company which had recently outlicensed its lead program, and was seeking input regarding the optimal path forward: inlicensing, internal development, or M&A.
2. An appraisal of all developmentally suitable neurological inlicensing opportunities for a multinational major pharmaceutical company.
3. Review and recommendations regarding clinical-stage inlicensing options for a 'development only' CNS specialty company
4. Assisted a major biotech information firm with identifying the most promising CNS licensing opportunities for a conference devoted to alliance and partnership building

Some comments from companies for whom NI Research has provided consultation:

“As an active participant in Neuromed’s strategic retreat, Dr. Harry Tracy provided an insightful presentation on the comparative effectiveness of the corporate strategies of multiple CNS small pharma companies and biotech. Dr. Tracy has comprehensive knowledge of the decisions and histories of CNS small pharma and biotech companies, a keen insight into the likely financial consequences of different key decisions and the willingness to lay out his reasoning and observations forthrightly. Dr. Tracy’s input was thorough, accurate, insightful, and pertinent to our task of mapping out the strategy for Neuromed’s future.”
--Christopher Gallen MD PhD, Chief Executive Officer, Neuromed Pharmaceuticals

“Opinions are cheap; data is cheap.  Opinions informed by data are rare and of enormous value.  That’s Harry Tracy and NI Research.  He knows the neuro market like no one we’ve ever seen; he forms his opinions – often counterintuitive – using an extraordinary database of clinical and scientific understanding and the kind of analytical creativity that grabs truth where it’s least expected.  We see that both in the consulting work he does (a crackerjack job in defining the most important licensable compounds) and in his writing in NeuroInvestment: expert analysis and opinion, authoritatively and honestly derived.”
--Roger Longman, Managing Director, Windhover Information Inc.

“Harry Tracy has a unique knowledge of the private company neuroscience space. We have found him to be extremely valuable as a consultant for our strategic process"
--Jeffrey McKelvy PhD, Chief Executive Officer, Avera Pharmaceuticals

Please contact us to discuss how NI Research can assist with strategic planning and licensing consultation. We also can provide specialists in M&A facilitation and financing.

Telephone: 760.230.2581

Email: info@neuroinvestment.com